| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10912171 | Lung Cancer | 2005 | 13 Pages |
Abstract
The role of surgery in the management of malignant pleural mesothelioma cannot be precisely defined as the lack of randomized controlled clinical trials makes it impossible to determine whether the use of EPP or PL improves survival or effectively palliates the symptoms of the disease. Future studies of the role of surgery in the treatment of mesothelioma should include evaluations of quality of life.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Donna E. Maziak, Anna Gagliardi, Adam E. Haynes, Jean A. Mackay, William K. Evans,